The stock's fall snapped a two-day winning streak.

Raymond James analyst Srini Pajjuri initiated coverage of Astera Labs (ALAB) with an Outperform rating and $82 price target Astera, a ...

A former Edward Jones advisor claims the company’s policies “expressly” favor diverse financial advisors and disadvantage ...

The federal government could be in for a shutdown in less than two days after Senate Democrats offered up a plan to play hardball and oppose a House bill that would keep the government open until ...

It’s just getting started. That’s the takeaway from analyst Michael W. Freeman, who initiated coverage of AIDX with a price ...

Raymond James Financial Inc. bought a new position in shares of Chemed Co. (NYSE:CHE – Free Report) during the fourth quarter ...

Raymond James Financial Inc. acquired a new stake in Comfort Systems USA, Inc. (NYSE:FIX – Free Report) during the fourth ...

Fintel reports that on March 12, 2025, Raymond James upgraded their outlook for Rayonier (NYSE:RYN) from Market Perform to Outperform. Analyst Price Forecast Suggests 17.66% Upside As of March 4, 2025 ...

This was the stock's second consecutive day of gains.

Rayonier ( NYSE: RYN) on Wednesday was upgraded to Outperform from a previous investment rating of Market Perform by analysts ...

What happened: The board listened to information related to financing options for two building projects the district is ...

Raymond James upgraded ICU Medical (ICUI) to Strong Buy from Outperform with a price target of $97, down from $205. The firm believes the ...